Amazon is diving deeper into the healthcare business as it launches its new unlimited prescription medication service for just $5 per month. The e-commerce firm has named the service RxPass, and it is exclusively offered to Prime members.
Subscribers of Amazon Pharmacy’s RxPass will be able to enjoy free delivery of medicines even if they order many times. The healthcare subscription service was launched on Tuesday this week and is now available in most states in the U.S.
Moreover, Prime members can also save on medicines since special discounts are also applied on top of the free delivery to homes. This service only shows that the company is slowly but continuously expanding its footprint in the healthcare market.
As per Fox Business, the $5 flat monthly fee covers various medicines, including antibiotic amoxicillin, naproxen anti-inflammatory drug, and sildenafil which is typically used for the treatment of erectile dysfunction. This is commonly known as Viagra and is also said to have the ability to treat some types of high blood pressure.
Even with the low subscription fee for RxPass, customers can fill as many prescriptions as they need. As long as the medicines are on the list, and Amazon said it has 50 generic medications. Some of the generic drugs are said to cost only $1 for a 30-day supply already. For other discounts, they can get up to 80% off on generic and 40% off on brand-name medicines; thus, the subscription is beneficial.
“Prime members already get fast, free delivery on prescription medications, and RxPass is one more way to save with Amazon Pharmacy. Any customer who pays more than $10 a month for their eligible medications will see their prescription costs drop by 50% or more, plus they save time by skipping a trip to the pharmacy,” Amazon Pharmacy’s vice president, John Love, said in a press release. “We are excited to offer our customers surprisingly simple, low pricing on the eligible medications they need each month.”
Photo by: Bastian Riccardi/Pixabay


Paraguay Central Bank Holds Interest Rate at 5.5% Amid Slowing Growth
China Holds Lending Rates Steady Amid Global Oil Price Surge and Middle East Tensions
Dollar Weakens as Middle East War Reshapes Global Rate Expectations
Iran War Fears Send Oil Prices Surging as U.S. Weighs Ground Troop Deployment
Goldman Sachs Delays Bank of England Rate Cut Forecast Amid Middle East Inflation Risks
OpenAI's Desktop Superapp: Unifying ChatGPT, Codex, and Browser Tools for Enterprise AI
Super Micro Computer Shares Plunge After Co-Founder Charged in AI Chip Smuggling Case
Asian Currencies Rebound as Dollar Weakens, BOJ Holds Rates
Amazon's "Transformer" Phone: Can It Succeed Where Fire Phone Failed?
Xiaomi's AI Model "Hunter Alpha" Mistaken for DeepSeek's Next Release
U.S. Stock Futures Steady as Wall Street Retreats on Oil Volatility and Fed Rate Outlook
Volkswagen CEO Urges Germany to Adopt China's Industrial Discipline Amid Major Restructuring
Genel Energy Reports FY25 Net Loss Below Fears, EBITDAX Beats Forecasts
U.S.-Iran War Escalates: Marines Deploy, Strait of Hormuz Closure Drives Global Oil Crisis
FEMSA Cuts Jobs at Spin Fintech Unit, Refocuses Strategy on Oxxo Stores
HSBC Considers Cutting 20,000 Jobs Amid AI-Driven Transformation
EA's $15B Debt Offering Draws $25B in Investor Demand Amid Credit Market Turmoil 



